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BACKGROUND: Waist circumference and hip circumference are both strongly associated with risk of death; however, their joint 
association has rarely been investigated.
METHODS AND RESULTS: The MONICA Risk, Genetics, Archiving, and Monograph (MORGAM) Project was conducted in 30 co-
horts from 11 countries; 90 487 men and women, aged 30 to 74 years, predominantly white, with no history of cardiovascular 
disease, were recruited in 1986 to 2010 and followed up for up to 24 years. Hazard ratios were estimated using sex- specific 
Cox models, stratified by cohort, with age as the time scale. Models included baseline categorical obesity measures, age, 
total and high- density lipoprotein cholesterol, systolic blood pressure, antihypertensive drugs, smoking, and diabetes mel-
litus. A total of 9105 all- cause deaths were recorded during a median follow- up of 10 years. Hazard ratios for all- cause death 
presented J- or U- shaped associations with most obesity measures. With waist and hip circumference included in the same 
model, for all hip sizes, having a smaller waist was strongly associated with lower risk of death, except for men with the small-
est hips. In addition, among those with smaller waists, hip size was strongly negatively associated with risk of death, with 
≈20% more people identified as being at increased risk compared with waist circumference alone.
CONCLUSIONS: A more complex relationship between hip circumference, waist circumference, and risk of death is revealed 
when both measures are considered simultaneously. This is particularly true for individuals with smaller waists, where having 
larger hips was protective. Considering both waist and hip circumference in the clinical setting could help to best identify those 
at increased risk of death.
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The prevalence of obesity is high or rapidly in-creasing in most countries, with serious health and economic consequences.1 Body mass index 
(BMI) is the most commonly used measure of obesity; 
however, it does not capture the differential effects 
of adipose tissue from different parts of the body2–8 
or visceral and subcutaneous adipose tissue.9 Body 
shape differences mean that people with the same 
BMI can vary widely in their body fat distribution.10 
BMI also does not distinguish between fat mass and 
fat- free mass, the latter having a strong inverse rela-
tionship with morbidity and mortality.8 The cost of the 
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imaging methods required to accurately assess fat dis-
tribution is prohibitive in many settings. From a public 
health perspective, it is therefore important to identify 
simple anthropometric measures that reflect adipose 
tissue distribution and are closely related to morbidity 
and premature death.
Waist circumference (WC) and hip circumference 
(HC) are commonly used and easily understood mea-
sures of abdominal (upper- body) and gluteofemoral 
(lower- body) body size, respectively. WC is primar-
ily a measure of visceral/ectopic and subcutaneous 
adipose tissue around the waist, whereas HC mea-
sures both adipose tissue and lower- body muscle 
mass. Numerous studies have shown that larger WC 
is strongly related to morbidity and premature death, 
while there is some evidence that larger HC is pro-
tective for these same outcomes.2,6,8,9,11 The effects 
of different fat depots in the upper and lower body 
are increasingly explained by variation in lipid storage 
and release11,12 and the secretion of adipose tissue- 
related proteins.5,11 Given their opposite relationships 
with metabolic health, the ratio of WC to HC (WHR) 
was conceptualized as an overall measure of obesity,13 
with the waist/height ratio also proposed as a way 
of capturing the distribution of body fat.14,15 WHR 
and waist/height ratio have a simple interpretation 
when the relationship between the 2 variables is lin-
ear, but lack interpretation otherwise.16 Furthermore, 
they can be identical for individuals of vastly different 
body shape.17 There is no conclusive evidence that 
WC alone or WHR is more strongly related to risk 
of premature death than BMI.18,19 Both, however, are 
predictors of death when added to a model also in-
cluding BMI, meaning they are clearly identifying dif-
ferent components of obesity- related risk.18 “A body 
shape index” (ABSI) that incorporates WC, height, 
and BMI has also been proposed in an attempt to 
identify an optimal body size measure associated 
with mortality.10
A 2013 systematic review identified only 5 studies 
predicting premature death using statistical models 
that included separate measures of both WC and HC.7 
In each case, the model including both measures was 
superior to a model including only one of them. These 
were single population studies with either a maximum 
follow- up of 12 years or <1500 deaths.
We aimed to conduct a novel assessment of the 
joint association of HC and WC with all- cause and car-
diovascular disease (CVD) mortality outcomes, strati-
fied by sex, using a large, multicountry cohort with long 
follow- up. We also report on the association between 




Details of data sharing arrangements and access to 
MONICA Risk, Genetics, Archiving, and Monograph 
(MORGAM) Project data are described in the following 
article: https://doi.org/10.1093/ije/dyh327. Please also 
see http://www.thl.fi/morgam. 
Study Population
The MORGAM Project is an ongoing multinational, 
collaborative study of prospective cohorts set up to 
investigate CVD.20 Participating centers in each coun-
try recruited cohorts by taking random samples of 
geographically defined populations at different time 
periods, with standardized risk factors measured at 
baseline at enrollment and participants followed up for 
death. Details of MORGAM cohorts and data quality 
assessments are documented online,21,22 with data 
CLINICAL PERSPECTIVE
What Is New?
• To the best of our knowledge, this is the most 
comprehensive investigation of the risk of death 
associated with different combinations of waist 
circumference and hip circumference, using 
data from >90 000 individuals (from 11 coun-
tries) who were followed up for up to 24 years.
What Are the Clinical Implications?
• Among those with smaller waists (who would 
not normally have been identified as being at 
higher risk of death on the basis of their body 
size), having smaller hips was strongly associ-
ated with increased risk of death.
• Considering both waist and hip circumference 
simultaneously identifies almost 20% more 
people as being at higher risk of death com-
pared with using waist circumference alone, 
and is a simple and cost-effective way of iden-
tifying body shapes associated with increased 
risk of premature death.
Nonstandard Abbreviations and Acronyms
ABSI  a body shape index
BMI  body mass index
CVD  cardiovascular disease
HC  hip circumference
MORGAM  MONICA Risk, Genetics, Archiving, 
and Monograph Project
WC  waist circumference
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harmonized according to the Monitoring of Trends and 
Determinants in Cardiovascular Disease (MONICA) 
and MORGAM manuals.21,23,24
Our study is based on data from 30 MORGAM 
cohorts from 17 participating centers located in 10 
European countries plus Australia, which included 
111  318 participants recruited between 1986 and 
2010 who were followed up for up to 24  years. 
Participants were excluded if they were aged <30 
years (n=6647; 6.0%) or ≥75 years (n=1863; 1.7%) at 
baseline, had missing information on follow- up period 
(n=473; 0.42%), had history of CVD (n=4916; 4.4%) or 
history of CVD was unknown (n=589; 0.53%), with 
some participants excluded for multiple reasons. Of 
the 97 189 (87.3%) participants eligible for this study, 
6702 (6.9%) were excluded as they had incomplete 
baseline data for CVD risk factors. Our final analysis 
sample included 90 487 participants (42 792 women), 
who were predominantly white, with a median fol-
low- up period of 10  years. Cohort characteristics 
are summarized by participating center and sex in 
Table  1. Each MORGAM participating center was 
responsible for ethical approval and patient con-
sent, according to local rules at the time of study 
enrollment.
End Points
Two end points were defined, all- cause and CVD 
death, via linkage to national or regional death reg-
istries. The follow- up of a person continued until the 
earliest one of the following events occurred: death; 
end of fixed follow- up period of the cohort; with-
drew from study; or lost to follow- up. Only 1.1% of 
the analysis sample withdrew or was lost to follow-
 up. CVD death was defined as death from coronary 
heart disease or stroke, in addition to unclassifiable 
deaths where there was insufficient evidence for cor-
onary origin. The diagnostic classification was based 
on validation of the cause of each death or on the 
International Classification of Diseases (ICD) codes 
of the routine death registration. Slight variation was 
present in ICD codes used because of local ICD cod-
ing practices (see description of MORGAM cohorts22 
for more details).
Baseline Measurements
Participants’ measures were collected at enrollment. 
Anthropometric measurements included weight in 
kilograms, and height, WC, and HC in meters.21 BMI 
was calculated as weight/height2. WHR and waist/
height ratio were calculated as WC/HC and WC/
height, respectively. ABSI was calculated as follows: 
WC/(BMI2/3×height1/2). Blood pressure was meas-
ured as the mean of the first 2 measurements taken 
in a sitting position using the right arm and using a 
standard or random zero sphygmomanometer, or an 
automated device, after a 5- minute rest, except in the 
United Kingdom and 3 French cohorts, in which blood 
pressure was measured only once using an automated 
device.21 Total serum cholesterol and high- density lipo-
protein cholesterol were analyzed in serum or plasma 
samples by local laboratories.21 Diabetes mellitus, 
use of antihypertensive drugs, and smoking of ciga-
rettes, cigars/cigarillos, or pipes were self- reported. 
History of CVD was identified from documentation (ie, 
population- based coronary event or stroke registers, 
person’s medical records, a hospital discharge regis-
ter, or other health information system) or self- reported 
history of myocardial infarction or stroke, including an-
gina pectoris when the data collected did not permit its 
separation from myocardial infarction.
Statistical Analysis
Anthropometric measures were categorized into 6 
groups based on sex- specific sample means and 
SDs of all available data (<−1 SD below the mean, −1 
to <−0.5 SDs below the mean, ≥−0.5–≤0.5 SDs from 
the mean, >0.5–1  SD above the mean, >1–2  SDs 
above the mean, and >2 SDs above the mean). The 
ranges of values for the categories are shown in 
Table S1.
Associations between the categorical anthropo-
metric measures and the risk of all- cause and car-
diovascular death were estimated separately for men 
and women using Cox proportional- hazards models, 
stratified by cohort, with age as the time scale, after 
partial and further adjustment. These associations 
were estimated in models including each individual 
anthropometric measure or a model including both 
WC and HC. Partially adjusted models included age 
at baseline (<50, 50–<55, 55–<60, 60–<65, 65–<70, 
and 70–<75 years). Further adjusted models included 
age and cardiovascular risk factors in the current ver-
sion of the Framingham Risk Score,25 all measured at 
baseline: log of total cholesterol (mmol/L), log of high- 
density lipoprotein cholesterol (mmol/L), systolic blood 
pressure (mm Hg), taking hypertension drugs (yes/no), 
current daily smoker (yes/no), and diabetes mellitus 
(yes/no). In the further adjusted model, interactions be-
tween baseline age and baseline measures, including 
anthropometric measures, were tested and retained 
if P<0.001. Main and interaction effects were tested 
using the Wald test. For models including both WC and 
HC, we estimated the hazard ratios only for feasible 
combinations of these body measurements (observed 
in >0.1% of the sample [Table S2]). The proportional- 
hazards assumption was checked using Schoenfeld 
residuals.
We performed complete case analyses, including 
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measures used in the analyses. We compared the 
characteristics of participants included in, and ex-
cluded from, the analysis sample (Table S3). We as-
sessed potential collinearity (and interaction) between 
WC and HC by creating a single joint measure of WC 
and HC, with 21 categories for women and 22 catego-
ries for men representing all WC and HC combinations. 
Some categories were combined to ensure sufficient 
numbers. The reference category was defined as both 
HC and WC being ≥−0.5 to ≤0.5 SDs from the mean. 
For both men and women, estimated hazard ratios for 
levels of the single joint measure were comparable to 
those obtained from models including WC and HC as 
separate measures (results not presented). Further sen-
sitivity analyses were performed for all- cause death, (1) 
excluding those who died <2 years from baseline, (2) 
excluding those reporting diabetes mellitus at baseline, 
and (3) including an interaction between daily smokers 
at baseline and each anthropometric measure. All sta-
tistical analyses were run using Stata 15.
RESULTS
Characteristics of Study Participants
The mean (SD) age of participants was 52.0 (10.8) 
years, and 52.7% were men. Anthropometric and other 
baseline measures are summarized by sex and survival 
status in Table 2. During a median (interquartile range) 
follow- up of 10.0 (10.4) years, 9105/90 487 (10.1%) par-
ticipants died from all causes, and 2577 (2.8%) died 
from cardiovascular causes. Follow- up periods and 
mortality rates are summarized by participating center 
and sex in Table 1.
Characteristics of participants included in the anal-
ysis and those excluded because of incomplete data 
were similar (Table S3), except that the analysis sam-
ple included a higher proportion of men (52.7% versus 
44.3%) and participants aged <50 years (40.7% versus 
31.8%).
Associations Between Individual 
Anthropometric Measures and Death
All anthropometric measures were strongly associated 
with risk of all- cause and CVD death, for both men and 
women, in both the partially and further adjusted mod-
els (Tables S4 through S7). Estimated adjusted hazard 
ratios for all- cause and CVD death, for each individual 
anthropometric measure relative to the reference cat-
egory (≥−0.5 to ≤0.5 SDs around mean), are shown by 
sex in Figure 1.
Further adjusted hazard ratios for all- cause death 
followed different patterns across levels of the obesity 
measures. A U- shaped pattern (increased risk for both 
the lowest and highest levels of the measure) was ob-
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in men. Risk increased monotonically with ABSI and 
WHR, with reduced risk for some categories below 
the mean. A J- shaped association was seen for waist/
height ratio for both men and women and for WC in 
women.
The further adjusted associations between the an-
thropometric measures and CVD death followed an 
essentially similar pattern, with wider CIs for both men 
and women.
Associations Between WC and HC 
Measures and Death
When both WC and HC were included as predictors 
of all- cause death in the same partially or further ad-
justed model (reference category ≥−0.5 to ≤0.5 SDs 
from the mean), both variables remained strongly as-
sociated with risk of death (P<0.0001; Tables S4 and 
S5). There was a monotonic relationship between 
WC and risk of death for both women and men. For 
women, further adjusted hazard ratios increased 
from 0.79 (95% CI, 0.68–0.91) for WC <−1 SD below 
the mean to 2.16 (95% CI, 1.72–2.71) for WC >2 SDs 
above the mean. For men, the further adjusted haz-
ard ratios increased from 0.90 (95% CI, 0.81–0.99) 
to 1.74 (95% CI, 1.46–2.08) in the smallest and larg-
est WC categories, respectively. In the same model, 
lower HC categories were associated with increased 
risk in women (<−1 SD below the mean: 1.72 [95% 
CI, 1.49–1.98]; −1 to <−0.5  SDs below the mean: 
1.27 [95% CI, 1.14–1.42]) and men (<−1  SD below 
the mean: 1.52 [95% CI, 1.37–1.69]; −1 to <−0.5 SDs 
Figure  1. Risk of death, according to obesity measures, by sex and cause of death, estimated after adjustment for 
cardiovascular risk factors.
Hazard ratios for all- cause (A and B) and cardiovascular (C and D) death by sex, with 95% CIs, are shown for each obesity measure: 
body mass index (BMI; weight in kilograms divided by the square of the height in meters), weight/hip ratio (WHR), a body shape 
index (ABSI; waist circumference in meters/[BMI2/3×height in meters½]), weight/height ratio (WHtR), waist circumference, and hip 
circumference. Vertical lines indicate 95% CIs. Reference category for each obesity measure was ≥−0.5 SDs to ≤0.5 SDs from the 
sample sex- specific mean. Risks were estimated from Cox proportional hazards models, stratified by cohort, and adjusted for age at 
baseline, log of total cholesterol (mmol/L), log of high- density lipoprotein (HDL) cholesterol (mmol/L), systolic blood pressure (mm Hg), 
taking antihypertensive drugs, current daily smoker (cigarettes, cigars/cigarillos, or pipe), diabetes mellitus, and all interactions 
between age and baseline measures that were statistically significant (P<0.001). †Additionally adjusted for an interaction between 
age at baseline and log of HDL cholesterol (mmol/L). #Additionally adjusted for interaction between age at baseline and systolic blood 
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below the mean: 1.13 [95% CI, 1.04–1.23]), with no 
increased risks for HC categories above the refer-
ence level.
We report the combined influence of HC and WC 
on risk of death in 2 ways, conditional on HC levels 
(Figure  2) and conditional on WC levels (Figure  3). 
Both figures show the estimated adjusted hazard ra-
tios for feasible combinations of WC and HC relative 
to the reference category (≥−0.5 to ≤0.5 SDs from the 
mean for both WC and HC). Figure 2 shows a strong, 
monotonic relationship between WC and risk of death 
for all HC categories, with smaller WC associated with 
lower risk of death, except for those with the smallest 
hips (<−1 SD below the mean in men). Figure 3 shows 
the pattern when considering the impact of HC for dif-
ferent levels of WC. For both men and women with a 
smaller waist (WC ≤1 SD above the mean: ≤98.8 cm in 
women and ≤105.7 cm in men), larger hips were asso-
ciated with a reduction in risk. For WC >1 SD above the 
mean, risk of death did not change with HC for men or 
women.
Similar patterns were seen for CVD death (Tables 
S6 and S7, Figures 1 through 3).
Sensitivity Analyses
Estimates were robust to excluding participants 
who died within 2 years from baseline (n=640; 0.7%) 
or those reporting diabetes mellitus at baseline 
(n=4028; 4.5%) (estimates not presented). We as-
sessed period effect; by adding decade of enroll-
ment to the further adjusted models. We found no 
statistical evidence of a period effect for both men 
and women (estimates not presented). To investigate 
Figure 2. Risk of death, according to waist circumference within hip circumference levels, by sex and cause of death, 
estimated after adjustment for cardiovascular risk factors.
Hazard ratios for all- cause (A and B) and cardiovascular (C and D) death by sex, with 95% CIs, are shown for all feasible combinations 
of waist circumference and hip circumference. Vertical lines indicate 95% CIs. Reference category was ≥−0.5 SDs to ≤0.5 SDs from 
the sample sex- specific mean for both waist circumference and hip circumference. Risks were estimated from Cox proportional 
hazards models, stratified by cohort, and adjusted for age at baseline, log of total cholesterol (mmol/L), log of high- density lipoprotein 
(HDL) cholesterol (mmol/L), systolic blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, cigars/
cigarillos, or pipe), diabetes mellitus, and all interactions between age and baseline measures that were statistically significant 
(P<0.001). †Additionally adjusted for an interaction between age at baseline and log of HDL cholesterol (mmol/L). #Additionally 
adjusted for an interaction between age at baseline and systolic blood pressure. &Additionally adjusted for an interaction between age 
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whether the U- or J- shaped relationship between 
mortality and some of the anthropometric measures 
could be explained by mortality due to diseases as-
sociated with smoking (which also affect anthropo-
metric measures), we fitted models that additionally 
included baseline smoking status and the interaction 
between smoking and anthropometric measures. 
The adjusted estimates for nonsmokers and smok-
ers are presented in Figure S1. Because the main aim 
of this analysis was to understand whether the shape 
of the association for the anthropometric categories 
was similar for smokers and nonsmokers, the hazard 
ratio estimates presented for smokers did not include 
the risk associated with smoking (ie, risk was esti-
mated using main effect of anthropometric measure 
plus the interaction term between smoking and the 
anthropometric measure). The shapes of the relation-
ships between the body measures and risk of death 
were similar.
DISCUSSION
This study of >90 000 predominantly white adults fol-
lowed up for up to 24 years provides evidence that it 
is important to consider measures of both upper- and 
lower- body adiposity when estimating risk of death. 
The most commonly used measures of obesity (BMI 
and WC) as well as HC displayed U- or J- shaped as-
sociations with risk of death from all causes. When 
both WC and HC were included together in models, a 
more nuanced and clearer picture was revealed, with 
2 distinct clinical messages. First, WC was strongly 
positively associated with risk of death at all hip sizes, 
except among those with the smallest hips (who al-
most all have WC well below the mean). In addition, 
among those with smaller waists, hip size was strongly 
negatively associated with risk of death. Among the 
people with smaller waists, who would not normally 
be identified as being at higher risk of death, having 
Figure 3. Risk of death, according to hip circumference within waist circumference levels, by sex and cause of death, 
estimated after adjustment for cardiovascular risk factors.
Hazard ratios for all- cause (A and B) and cardiovascular (C and D) death by sex, with 95% CIs, are shown for all feasible combinations 
of waist circumference and hip circumference. Vertical lines indicate 95% CIs. Reference category was ≥−0.5 SDs to ≤0.5 SDs from 
the sample sex- specific mean for both waist circumference and hip circumference. Risks were estimated from Cox proportional 
hazards models, stratified by cohort, and adjusted for age at baseline, log of total cholesterol (mmol/L), log of high- density lipoprotein 
(HDL) cholesterol (mmol/L), systolic blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, cigars/
cigarillos, or pipe), diabetes mellitus, and all interactions between age and baseline measures that were statistically significant 
(P<0.001). †Additionally adjusted for an interaction between age at baseline and log of HDL cholesterol (mmol/L). #Additionally 
adjusted for an interaction between age at baseline and systolic blood pressure. &Additionally adjusted for an interaction between age 
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smaller hips was clearly associated with increased risk 
of death. In our sample, by considering both WC and 
HC, rather than just WC, an additional 19% of women 
and 18% of men would be identified as being at higher 
risk of death. These results demonstrate the value of 
considering body shape using both WC and HC, and 
contribute to the growing literature on the impact of 
body fat depots in different parts of the body on risk of 
death, as well as the evidence for the protective effects 
of fat- free mass.2,4,6,8,11
Like others10, we found that ABSI was a strong 
predictor of death. This suggests that ABSI could be 
useful in the research setting, particularly because it 
is a single measure of obesity. It may also have some 
value in clinical settings if simple calculators based on 
population norms were created. From a public health 
perspective, ABSI is likely to be less useful because of 
the inherent challenges in communicating messages 
about risk of death using a highly complex concept 
and measure.
Our findings add to the small but growing literature 
examining the combined effect of WC and HC as pre-
dictors of death. A 2013 literature review on the topic 
found 5 studies that all suggested the strength of as-
sociations between WC and death is underestimated 
without also considering HC.7 Compared with these 
studies (and one published since),26 our study used a 
larger, multicountry cohort with longer follow- up and a 
substantial number of deaths. Hazard ratios for com-
bined categories of WC and HC have only previously 
been estimated in our earlier study among South 
Asian and African Mauritians.27 The current finding that 
larger HC is protective only for people with smaller WC 
agrees with evidence from that Mauritian study. The 
stronger relationship between WC and HC and risk of 
death observed in Mauritius may be due to the consid-
erably lower WCs observed in that population (median 
[interquartile range] WC, 90.5  [17.0] cm for survivors 
and 94.0  [17.0] cm for those who died from CVD in 
this sample compared with 79.5 [15.2] cm for survivors 
and 84.0  [15.5] cm for those who died from CVD in 
Mauritius).27 It is possible that in the many populations 
worldwide that currently have a larger mean WC than 
observed in the historic MORGAM cohort, the pro-
tective effect of HC may be less pronounced. Further 
studies among populations with different prevalence 
of obesity at baseline will be important to confirm this 
hypothesis. Unfortunately, heterogeneity of findings 
across participating cohorts could not be tested within 
our analytical framework because of the small number 
of deaths in some, and different survey periods and 
age profiles.
Although the physiological basis for the opposing 
effects of WC and HC is not completely clear, some 
hypotheses for the protective effects of lower- body 
gluteofemoral adipose tissue, and the particularly 
detrimental effects of visceral adipose tissue, have 
been put forward.11,12 These include clear differences 
in the ability of the cells in different depots to store and 
release lipids and the secretion of proteins, such as 
leptin and adiponectin (positively associated), as well 
as inflammatory cytokines (negatively associated).11 In 
addition to these metabolic differences, lower- body 
anthropometric measures are also capturing fat- free 
(muscle) mass in the thigh and buttocks. Greater mus-
cle mass is likely to be indicative of greater levels of 
physical activity and less time sedentary, which are 
both protective against premature death,28,29 whereas 
smaller hips could reflect overall smaller frame size 
or result from health conditions influenced by lifestyle 
behaviors. More important, although body shape 
changes with age, the associations observed were ro-
bust across all age groups (up to age 75 years). An 
extensive literature exists on the association between 
HC or thigh circumference (relative to WC) and a range 
of metabolic risk markers and disease outcomes, in-
cluding dyslipidemia, hypertension, and diabetes mel-
litus,2–4 in addition to the all- cause and CVD mortality 
observed here.
It is possible that strength training interventions 
that increase muscle in the hips or thighs without also 
increasing waist may reduce risk in addition to inter-
ventions that target reduction in WC. Although that hy-
pothesis is untested, a Scandinavian study showed no 
reduction in risk of death among those who reduced 
their HC over time. That study, however, did not spe-
cifically assess the corresponding changes in WC for 
those who reduced their HC.26 A Danish study found 
that the risk of death from small hips was partially at-
tenuated by physical activity.30
Strengths of this study include the large sample 
size from 30 cohorts in 11 countries, the consistent 
methods for measurement of baseline factors and as-
certainment of outcomes, and that findings were ro-
bust across multiple sensitivity analyses. Limitations 
include the inability to exclude participants with a di-
agnosis of cancer, respiratory disease, or abdominal 
distension (not measured) or pregnancy (recorded in 
<50% of cohorts), the absence of information on po-
tential confounders, such as physical activity and sed-
entary behavior, the self- report of diabetes mellitus 
history, and the low incidence of CVD death observed. 
Furthermore, as all measures were collected at base-
line, we were unable to investigate the variation in body 
measures and CVD risk factors over time and the rela-
tionship with the risk of death.
In conclusion, this study provides evidence that a 
more complex relationship between HC, WC, and risk 
of death is revealed when both measures are consid-
ered simultaneously. Considering both WC and HC in 
the clinical setting could help best identify those at in-
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below the mean 
-1 to <-½SD
below the mean 
≥-½ to ≤½SD 
from the mean 
>½ to 1SD
above the mean 
>1 to 2SD
above the mean 
>2SD
above the mean 
Body mass index (kg/m2)+ 
 Females <21.8 21.8 - <24.3 24.3 - 29.4 >29.4 - 32.0 >32.0 - 37.1 >37.1
   Males <23.3 23.3 - <25.2 25.2 - 29.0 >29.0 - 30.9 >30.9 - 34.8 >34.8
Waist-to-hip ratio 
 Females <0.76 0.76 - <0.80 0.80 - 0.87 >0.87 - 0.91 >0.91 - 0.99 >0.99
 Males <0.88 0.88 - <0.91 0.91 - 0.97 >0.97 - 1.01 >1.01 - 1.07 >1.07
A body shape index† 
 Females <0.070 0.070 - <0.073 0.073 - 0.079 >0.079 - 0.082 >0.082 - 0.088 >0.088
   Males  <0.076 0.076 - <0.078 0.078 - 0.083 >0.083 - 0.085 >0.085 - 0.089 >0.089
Waist-to-height ratio 
 Females <0.45 0.45 - <0.49 0.49 - 0.58 >0.58 - 0.63 >0.63 - 0.71 >0.71
 Males <0.49 0.49 - <0.52 0.52 - 0.58 >0.58 - 0.61 >0.61 - 0.68 >0.68
Waist circumference (cm) 
 Females <72.8 72.8 - <79.3 79.3 - 92.3 >92.3 - 98.8 >98.8 - 111.8 >111.8
   Males <84.8 84.8 - <90.0 90.0 - 100.5 >100.5 - 105.7 >105.7 - 116.2 >116.2
Hip circumference (cm) 
 Females <92.5 92.5 - <97.6 97.6 - 107.7 >107.7 - 112.8 >112.8 - 123.0 >123.0
 Males <93.3 93.3 - <97.2 97.2 - 104.8 >104.8 - 108.6 >108.6 - 116.2 >116.2
+ Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters.
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below the mean 
-1 to <-½SD
below the mean 
≥-½ to ≤½SD 
from the mean 
>½ to 1SD
above the mean 
>1 to 2SD
above the mean 
>2SD
above the mean 
n (%) n (%) n (%) n (%) n (%) n (%) 
FEMALES (N=42,792) 
<-1SD below the mean 3,528 (8.2) 2,282 (5.3) 880 (2.1) 23 (0.054) 2 (0.0047) 0 (0) 
-1 to <-½SD below the mean 1,508 (3.5) 3,344 (7.8) 3,486 (8.1) 142 (0.33) 18 (0.042) 1 (0.0023) 
≥-½ to ≤½SD from the mean 623 (1.5) 2,443 (5.7) 9,548 (22) 2,163 (5.1) 709 (1.7) 21 (0.049) 
>½ to 1SD above the mean 33 (0.077) 207 (0.48) 2,136 (5.0) 1,406 (3.3) 1,245 (2.9) 101 (0.24) 
>1 to 2SD above the mean 23 (0.054) 75 (0.18) 1,217 (2.8) 1,206 (2.8) 2,060 (4.8) 726 (1.7) 
>2SD above the mean 1 (0.0023) 7 (0.016) 67 (0.16) 125 (0.29) 552 (1.3) 884 (2.1) 
MALES (N=47,695)
<-1SD below the mean 3,718 (7.8) 2,054 (4.3) 1,115 (2.3) 30 (0.063) 5 (0.010) 0 (0) 
-1 to <-½SD below the mean 1,910 (4.0) 2,964 (6.2) 3,718 (7.8) 226 (0.47) 50 (0.10) 2 (0.0042) 
≥-½ to ≤½SD from the mean 965 (2.0) 3,034 (6.4) 11,020 (23) 2,852 (6.0) 747 (1.6) 23 (0.048) 
>½ to 1SD above the mean 39 (0.082) 207 (0.43) 2,587 (5.4) 2,120 (4.4) 1,285 (2.7) 39 (0.082) 
>1 to 2SD above the mean 11 (0.023) 49 (0.10) 906 (1.9) 1,478 (3.1) 2,577 (5.4) 462 (1.0) 
>2SD above the mean 0 (0) 1 (0.0021) 37 (0.078) 87 (0.18) 506 (1.1) 871 (1.8) D
ow
nloaded from
 http://ahajournals.org by on January 22, 2021
Table S3. Summary of follow-up times, mortality rates and baseline characteristics of 
participants included in and excluded from the analysis sample.
Characteristic  Analysis 
Sample^ 
Excluded from analysis 
sample$
(N=90,487) (N=6,702) 
n (%)  N¥ (%)# n (%) 
Survival 
   All-cause deaths  9,105 (10.1) 6,702 (100) 777 (11.6) 
   CVD deaths 2,577 (2.8) 6,702 (100) 241 (3.6) 
   Median (IQR) follow-up (years) 10.0 (10.4) 6,702 (100) 9.5 (6.8) 
   Mean (SD) age died/censored (years) 63.1 (11.4) 6,702 (100) 63.6 (11.1)
Demographics 
   Male 47,695 (52.7) 6,702 (100) 2,966 (44.3)
   Mean (SD) age (years) 52.0 (10.8) 6,702 (100) 52.4 (10.4)
   Age (years) 6,702 (100)
       <50 36,798 (40.7) 2,131 (31.8) 
       50 - <55 15,739 (17.4) 1,997 (29.8) 
       55 - <60 16,413 (18.1) 1,126 (16.8) 
       60 - <65 10,468 (11.6) 651 (9.7) 
 65 - <70 6,561 (7.3) 428 (6.4) 
 70 - <75 4,508 (5.0) 369 (5.5) 
Body measurements 
   Body mass index 5,924 (88.4) 
 <-1SD below the mean 12,587 (13.9) 831 (14.0) 
-1 to <-½SD below the mean 17,793 (19.7) 1,196 (20.2)  
≥-½ to ≤½SD from the mean 36,066 (39.9) 2,315 (39.1) 
>½ to 1SD above the mean 10,744 (11.9) 678 (11.4) 
>1 to 2SD above the mean 9,803 (10.8) 649 (11.0) 
>2SD above the mean 3,494 (3.9) 255 (4.3) 
   Waist-to-hip ratio 3,918 (58.5) 
 <-1SD below the mean 12,661 (14.0) 377 (9.6) 
-1 to <-½SD below the mean 17,454 (19.3) 586 (15.0) 
≥-½ to ≤½SD from the mean 34,932 (38.6) 1,598 (40.8) 
>½ to 1SD above the mean 11,901 (13.2) 585 (14.9) 
>1 to 2SD above the mean 10,535 (11.6) 587 (15.0) 
>2SD above the mean 3,004 (3.3) 185 (4.7) 
   A body shape index† 3,854 (57.5) 
       <-1SD below the mean 13,037 (14.4) 530 (13.8) 
-1 to <-½SD below the mean 15,582 (17.2) 696 (18.1) 
≥-½ to ≤½SD from the mean 36,221 (40.0) 1,560 (40.5) 
>½ to 1SD above the mean 11,947 (13.2) 546 (14.2) 
>1 to 2SD above the mean 10,810 (11.9) 397 (10.3) 
>2SD above the mean 2,890 (3.2) 125 (3.2) 
   Waist-to-height ratio 3,878 (57.9)
 <-1SD below the mean 14,002 (15.5) 549 (14.2) 
-1 to <-½SD below the mean 16,583 (18.3) 675 (17.4) 
≥-½ to ≤½SD from the mean 34,394 (38.0) 1,456 (37.5) 
>½ to 1SD above the mean 11,571 (12.8) 524 (13.5) 
>1 to 2SD above the mean 10,722 (11.8) 494 (12.7) 
>2SD above the mean 3,215 (3.6) 180 (4.6) 
   Waist circumference  3,948 (58.9) 
 <-1SD below the mean 13,637 (15.1) 535 (13.6) 
-1 to <-½SD below the mean 17,369 (19.2) 713 (18.1) 
≥-½ to ≤½SD from the mean 34,148 (37.7) 1,433 (36.3) 
>½ to 1SD above the mean 11,405 (12.6) 540 (13.7) 
>1 to 2SD above the mean 10,790 (11.9) 524 (13.3) 
>2SD above the mean 3,138 (3.5) 203 (5.1) 
   Hip circumference  3,930 (58.6) 
 <-1SD below the mean 12,359 (13.7) 640 (16.3) 
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 ≥-½ to ≤½SD from the mean 36,717 (40.6) 1,455 (37.0) 
>½ to 1SD above the mean 11,858 (13.1) 515 (13.1) 
>1 to 2SD above the mean 9,756 (10.8) 409 (10.4) 
>2SD above the mean 3,130 (3.5) 178 (4.5) 
Other vascular risk factors 
   Mean (SD) total cholesterol (mmol/l) 5.81 (1.15) 5,690 (84.9) 6.06 (1.26) 
   Median (IQR) total cholesterol (mmol/l) 5.70 (1.50) 5,690 (84.9) 5.90 (1.60) 
   Mean (SD) HDL cholesterol (mmol/l) 1.43 (0.40) 5,591 (83.4) 1.52 (0.43) 
   Median (IQR) HDL cholesterol (mmol/l) 1.39 (0.50) 5,591 (83.4) 1.47 (0.56) 
   Mean (SD) systolic blood pressure (mm Hg) 136 (21) 6,011 (89.7) 141 (21) 
   Taking antihypertensive drugs  14,367 (15.9) 4,202 (62.7) 538 (12.8) 
   Current daily smoker  22,545 (24.9) 6,587 (98.3) 1,889 (28.7) 
   Diabetes  4,028 (4.5) 5,797 (86.5) 232 (4.0) 
^   Included in the analysis sample, complete data for all analysis measures. 
$   Excluded from the analysis sample, missing data for one of more of the analysis variables. 
¥ Number of participants with incomplete data who had data for the measure. For ordinal measures, sample size
shown next to variable name.
#   Percent of participants with incomplete data who had data for the measure. For ordinal measures percent
shown next to variable name
&   Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters.
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Table S4. Estimated risk of death from all-causes among females (N=42,792) according to 
categorical body measurement categories under partial and full adjustment$ 
Body measurement Number of Number of Partially adjusted# Further adjusted&
people deaths HR (95% CI) p-value  HR (95% CI) p-value 
Body mass index (kg/m2)+ 
   <-1SD below the mean 5,935 417 1.44 (1.28 - 1.61) 4 x 10-20 1.40 (1.25 - 1.58) 8 x 10-12 
-1 to <-½SD below the mean 9,126 602 1.13 (1.02 - 1.25) 1.15 (1.04 - 1.27) 
 ≥-½ to ≤½SD from the mean 16,325 1,219 1.00 1.00 
>½ to 1SD above the mean 4,780 437 1.16 (1.04 - 1.29) 1.09 (0.98 - 1.22) 
>1 to 2SD above the mean 4,859 470 1.43 (1.28 - 1.59) 1.29 (1.16 - 1.44) 
>2SD above the mean 1,767 177 1.84 (1.57 - 2.16) 1.54 (1.31 - 1.81) 
Waist-to-hip ratio 
  <-1SD below the mean 6,148 338 0.79 (0.70 - 0.89) 4 x 10-26 0.87 (0.77 - 0.98) 1 x 10-12 
-1 to <-½SD below the mean 8,125 599 0.88 (0.80 - 0.97) 0.93 (0.84 - 1.02) 
 ≥-½ to ≤½SD from the mean 16,988 1,457 1.00 1.00 
>½ to 1SD above the mean 5,229 488 1.30 (1.17 - 1.44) 1.23 (1.11 - 1.37) 
>1 to 2SD above the mean 4,618 349 1.53 (1.36 - 1.72) 1.40 (1.24 - 1.58) 
>2SD above the mean 1,684 91 1.82 (1.45 - 2.27) 1.60 (1.28 - 2.00) 
A body shape index† 
  <-1SD below the mean 5,992 332 0.71 (0.63 - 0.80) 5 x 10-29 0.78 (0.68 - 0.88) 2 x 10-17 
-1 to <-½SD below the mean 8,248 534 0.79 (0.71 - 0.87) 0.83 (0.75 - 0.91) 
 ≥-½ to ≤½SD from the mean 16,983 1,495 1.00 1.00 
>½ to 1SD above the mean 4,818 495 1.29 (1.16 - 1.43) 1.19 (1.08 - 1.33) 
>1 to 2SD above the mean 4,932 372 1.39 (1.23 - 1.56) 1.32 (1.17 - 1.48) 
>2SD above the mean 1,819 94 1.90 (1.52 - 2.38) 1.74 (1.39 - 2.18) 
Waist-to-height ratio 
  <-1SD below the mean 6,862 374 1.04 (0.92 - 1.17) 1 x 10-23 1.05 (0.93 - 1.19) 6 x 10-12 
-1 to <-½SD below the mean 8,514 592 0.99 (0.90 - 1.10) 1.01 (0.91 - 1.11) 
 ≥-½ to ≤½SD from the mean 15,219 1,258 1.00 1.00 
>½ to 1SD above the mean 5,264 473 1.19 (1.07 - 1.33) 1.12 (1.01 - 1.25) 
>1 to 2SD above the mean 5,290 494 1.56 (1.40 - 1.74) 1.43 (1.28 - 1.59) 
>2SD above the mean 1,643 131 2.09 (1.73 - 2.51) 1.72 (1.43 - 2.08) 
Waist circumference (cm) 
   <-1SD below the mean 6,715 393 1.09 (0.97 - 1.23) 4 x 10-28 1.10 (0.98 - 1.24) 7 x 10-15 
-1 to <-½SD below the mean 8,499 600 1.00 (0.91 - 1.10) 1.03 (0.93 - 1.13) 
 ≥-½ to ≤½SD from the mean 15,507 1,227 1.00 1.00 
>½ to 1SD above the mean 5,128 459 1.20 (1.08 - 1.34) 1.14 (1.02 - 1.27) 
>1 to 2SD above the mean 5,307 492 1.51 (1.36 - 1.68) 1.40 (1.26 - 1.56) 
>2SD above the mean 1,636 151 2.32 (1.95 - 2.75) 1.92 (1.61 - 2.29) 
Hip circumference (cm) 
   <-1SD below the mean 5,716 414 1.52 (1.35 - 1.71) 4 x 10-20 1.45 (1.29 - 1.63) 7 x 10-13 
-1 to <-½SD below the mean 8,358 549 1.14 (1.03 - 1.26) 1.15 (1.04 - 1.28) 
 ≥-½ to ≤½SD from the mean 17,334 1,251 1.00 1.00 
>½ to 1SD above the mean 5,065 433 1.07 (0.96 - 1.20) 1.03 (0.92 - 1.15) 
>1 to 2SD above the mean 4,586 491 1.39 (1.25 - 1.54) 1.29 (1.16 - 1.43) 
>2SD above the mean 1,733 184 1.71 (1.46 - 2.00) 1.47 (1.25 - 1.72) 
Waist & hip circumference 
  Waist 
   <-1SD below the mean 6,715 393 0.72 (0.62 - 0.83) 2 x 10-24 0.79 (0.68 - 0.91) 2 x 10-13 
 -1 to <-½SD below the mean 8,499 600 0.83 (0.74 - 0.92) 0.88 (0.79 - 0.98) 
 ≥-½ to ≤½SD from the mean 15,507 1,227 1.00 1.00 
 >½ to 1SD above the mean 5,128 459 1.30 (1.15 - 1.46) 1.21 (1.08 - 1.37) 
 >1 to 2SD above the mean 5,307 492 1.67 (1.46 - 1.91) 1.52 (1.32 - 1.74) 
 >2SD above the mean 1,636 151 2.67 (2.14 - 3.34) 2.16 (1.72 - 2.71) 
   Hip 
   <-1SD below the mean 5,716 414 1.95 (1.69 - 2.25) 1 x 10-18 1.72 (1.49 - 1.98) 5 x 10-12 
 -1 to <-½SD below the mean 8,358 549 1.33 (1.19 - 1.48) 1.27 (1.14 - 1.42) 
 ≥-½ to ≤½SD from the mean 17,334 1,251 1.00 1.00 
 >½ to 1SD above the mean 5,065 433 0.90 (0.80 - 1.01) 0.91 (0.81 - 1.02) 
 >1 to 2SD above the mean 4,586 491 0.96 (0.84 - 1.09) 0.97 (0.85 - 1.11) 
 >2SD above the mean 1,733 184 0.87 (0.71 - 1.07) 0.89 (0.72 - 1.09) 
$   HR hazard ratio. CI confidence interval. Estimated separately for males and females using Cox proportional 
hazards models, stratified by cohort, with age at death/censoring as the time variable. 
#    Adjusted for age at baseline. 
&   Adjusted for age at baseline, log of total cholesterol (mmol/l), log of HDL cholesterol (mmol/l), systolic 
blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, cigars/cigarillos or 
pipe), diabetes, and an interaction between age at baseline and log of HDL cholesterol (mmol/l). 
+ Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters.
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Table S5. Estimated risk of death from all-causes among males (N= 47,695) according to categorical 
body measurement categories under partial and full adjustment$ 
Body measurement Number of Number of Partially adjusted# Further adjusted&
people deaths HR (95% CI) p-value  HR (95% CI) p-value 
Body mass index (kg/m2)+ 
   <-1SD below the mean 6,652 997 1.49 (1.38 - 1.60) 3 x 10-36 1.34 (1.24 - 1.45) 6 x 10-18 
-1 to <-½SD below the mean 8,667 1,003 1.09 (1.01 - 1.18) 1.07 (0.99 - 1.16) 
 ≥-½ to ≤½SD from the mean 19,741 2,146 1.00 1.00 
>½ to 1SD above the mean 5,964 706 1.17 (1.08 - 1.28) 1.14 (1.05 - 1.24) 
>1 to 2SD above the mean 4,944 679 1.34 (1.23 - 1.46) 1.23 (1.12 - 1.34) 
>2SD above the mean 1,727 252 1.84 (1.61 - 2.10) 1.55 (1.35 - 1.77)
Waist-to-hip ratio 
  <-1SD below the mean 6,513 686 0.94 (0.86 - 1.03) 7 x 10-35 0.95 (0.86 - 1.04) 2 x 10-19 
-1 to <-½SD below the mean 9,329 1,035 0.96 (0.89 - 1.04) 0.98 (0.91 - 1.06) 
 ≥-½ to ≤½SD from the mean 17,944 2,045 1.00 1.00 
>½ to 1SD above the mean 6,672 877 1.19 (1.10 - 1.29) 1.15 (1.06 - 1.25) 
>1 to 2SD above the mean 5,917 917 1.46 (1.35 - 1.58) 1.36 (1.26 - 1.48) 
>2SD above the mean 1,320 223 1.85 (1.61 - 2.13) 1.58 (1.37 - 1.82) 
A body shape index† 
  <-1SD below the mean 7,045 580 0.86 (0.78 - 0.95) 2 x 10-58 0.89 (0.81 - 0.98) 8 x 10-39 
-1 to <-½SD below the mean 7,334 661 0.90 (0.83 - 0.99) 0.93 (0.85 - 1.02) 
 ≥-½ to ≤½SD from the mean 19,238 2,065 1.00 1.00 
>½ to 1SD above the mean 7,129 1,032 1.24 (1.15 - 1.33) 1.21 (1.12 - 1.31) 
>1 to 2SD above the mean 5,878 1,153 1.53 (1.42 - 1.65) 1.43 (1.33 - 1.54) 
>2SD above the mean 1,071 292 2.07 (1.82 - 2.34) 1.82 (1.60 - 2.06) 
Waist-to-height ratio 
  <-1SD below the mean 7,140 764 1.16 (1.07 - 1.26) 4 x 10-35 1.08 (0.99 - 1.18) 9 x 10-20 
-1 to <-½SD below the mean 8,069 882 1.00 (0.92 - 1.08) 1.00 (0.92 - 1.08) 
 ≥-½ to ≤½SD from the mean 19,175 2,161 1.00 1.00 
>½ to 1SD above the mean 6,307 841 1.16 (1.07 - 1.25) 1.15 (1.06 - 1.24) 
>1 to 2SD above the mean 5,432 835 1.38 (1.27 - 1.50) 1.29 (1.18 - 1.40) 
>2SD above the mean 1,572 300 2.03 (1.80 - 2.30) 1.75 (1.54 - 1.98) 
Waist circumference (cm) 
   <-1SD below the mean 6,922 819 1.22 (1.13 - 1.33) 6 x 10-32 1.13 (1.03 - 1.23) 1 x 10-16 
-1 to <-½SD below the mean 8,870 975 1.05 (0.97 - 1.13) 1.05 (0.97 - 1.13) 
 ≥-½ to ≤½SD from the mean 18,641 2,058 1.00 1.00 
>½ to 1SD above the mean 6,277 785 1.10 (1.01 - 1.19) 1.07 (0.98 - 1.16) 
>1 to 2SD above the mean 5,483 884 1.41 (1.30 - 1.53) 1.31 (1.21 - 1.42) 
>2SD above the mean 1,502 262 1.93 (1.70 - 2.20) 1.63 (1.43 - 1.87) 
Hip circumference (cm) 
   <-1SD below the mean 6,643 853 1.49 (1.37 - 1.62) 2 x 10-26 1.36 (1.25 - 1.49) 4 x 10-16 
-1 to <-½SD below the mean 8,309 921 1.10 (1.01 - 1.18) 1.06 (0.98 - 1.15) 
 ≥-½ to ≤½SD from the mean 19,383 2,163 1.00 1.00 
>½ to 1SD above the mean 6,793 901 1.07 (0.99 - 1.15) 1.08 (0.99 - 1.16) 
>1 to 2SD above the mean 5,170 713 1.20 (1.10 - 1.31) 1.17 (1.07 - 1.27) 
>2SD above the mean 1,397 232 1.67 (1.45 - 1.91) 1.52 (1.32 - 1.74) 
Waist & hip circumference 
  Waist 
   <-1SD below the mean 6,922 819 0.90 (0.81 - 0.99) 1 x 10-27 0.90 (0.81 - 0.99) 7 x 10-13 
 -1 to <-½SD below the mean 8,870 975 0.92 (0.85 - 1.00) 0.95 (0.88 - 1.04) 
 ≥-½ to ≤½SD from the mean 18,641 2,058 1.00 1.00 
 >½ to 1SD above the mean 6,277 785 1.20 (1.10 - 1.31) 1.13 (1.03 - 1.23) 
 >1 to 2SD above the mean 5,483 884 1.62 (1.47 - 1.79) 1.42 (1.28 - 1.56) 
 >2SD above the mean 1,502 262 2.26 (1.90 - 2.70) 1.74 (1.46 - 2.08) 
   Hip 
   <-1SD below the mean 6,643 853 1.71 (1.54 - 1.90) 6 x 10-23 1.52 (1.37 - 1.69) 2 x 10-12 
 -1 to <-½SD below the mean 8,309 921 1.20 (1.10 - 1.31) 1.13 (1.04 - 1.23) 
 ≥-½ to ≤½SD from the mean 19,383 2,163 1.00 1.00 
 >½ to 1SD above the mean 6,793 901 0.91 (0.83 - 0.99) 0.96 (0.89 - 1.05) 
 >1 to 2SD above the mean 5,170 713 0.85 (0.76 - 0.94) 0.92 (0.82 - 1.02) 
 >2SD above the mean 1,397 232 0.89 (0.74 - 1.07) 1.00 (0.83 - 1.20) 
$   HR hazard ratio. CI confidence interval. Estimated separately for males and females using Cox proportional 
hazards models, stratified by cohort, with age at death/censoring as the time variable. #   Adjusted for age at 
baseline. &   Adjusted for age at baseline, log of total cholesterol (mmol/l), log of HDL cholesterol (mmol/l), 
systolic blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, 
cigars/cigarillos or pipe), diabetes, and an interaction between age at baseline and current daily smoker. +  
Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. †   A body 
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Table S6. Estimated risk of death from cardiovascular disease among females (N=42,792) according to 
categorical body measurement categories under partial and full adjustment$ 
Body measurement Number of Number of Partially adjusted# Further adjusted&
people deaths HR (95% CI) p-value  HR (95% CI) p-value 
Body mass index (kg/m2)+
   <-1SD below the mean 5,935 92 1.15 (0.90 - 1.45) 3 x 10-10 1.22 (0.96 - 1.56) 9 x 10-4 
-1 to <-½SD below the mean 9,126 153 1.06 (0.87 - 1.28) 1.18 (0.97 - 1.43) 
 ≥-½ to ≤½SD from the mean 16,325 333 1.00 1.00 
>½ to 1SD above the mean 4,780 151 1.45 (1.19 - 1.76) 1.29 (1.06 - 1.57) 
>1 to 2SD above the mean 4,859 124 1.43 (1.16 - 1.76) 1.17 (0.94 - 1.44) 
>2SD above the mean 1,767 62 2.51 (1.90 - 3.30) 1.82 (1.37 - 2.41)
Waist-to-hip ratio 
  <-1SD below the mean 6,148 77 0.64 (0.50 - 0.82) 5 x 10-16 0.80 (0.63 - 1.04) 3 x 10-5 
-1 to <-½SD below the mean 8,125 144 0.72 (0.60 - 0.87) 0.83 (0.69 - 1.01) 
 ≥-½ to ≤½SD from the mean 16,988 422 1.00 1.00 
>½ to 1SD above the mean 5,229 136 1.26 (1.04 - 1.53) 1.15 (0.94 - 1.39) 
>1 to 2SD above the mean 4,618 107 1.73 (1.40 - 2.15) 1.46 (1.18 - 1.82) 
>2SD above the mean 1,684 29 2.37 (1.60 - 3.52) 1.77 (1.19 - 2.62) 
A body shape index† 
  <-1SD below the mean 5,992 81 0.64 (0.50 - 0.82) 3 x 10-14 0.77 (0.60 - 0.99) 6 x 10-8 
-1 to <-½SD below the mean 8,248 151 0.83 (0.69 - 1.01) 0.91 (0.75 - 1.10) 
 ≥-½ to ≤½SD from the mean 16,983 405 1.00 1.00 
>½ to 1SD above the mean 4,818 151 1.46 (1.21 - 1.76) 1.28 (1.06 - 1.55) 
>1 to 2SD above the mean 4,932 93 1.33 (1.06 - 1.68) 1.21 (0.96 - 1.53) 
>2SD above the mean 1,819 34 3.02 (2.09 - 4.38) 2.75 (1.89 - 3.98) 
Waist-to-height ratio 
  <-1SD below the mean 6,862 76 0.73 (0.56 - 0.94) 8 x 10-14 0.83 (0.64 - 1.08) 1 x 10-3 
-1 to <-½SD below the mean 8,514 139 0.79 (0.65 - 0.96) 0.87 (0.71 - 1.07) 
 ≥-½ to ≤½SD from the mean 15,219 370 1.00 1.00 
>½ to 1SD above the mean 5,264 147 1.30 (1.07 - 1.57) 1.11 (0.92 - 1.35) 
>1 to 2SD above the mean 5,290 146 1.65 (1.36 - 2.01) 1.36 (1.12 - 1.67) 
>2SD above the mean 1,643 37 2.37 (1.68 - 3.35) 1.63 (1.15 - 2.32) 
Waist circumference (cm) 
   <-1SD below the mean 6,715 77 0.71 (0.55 - 0.92) 2 x 10-15 0.80 (0.62 - 1.04) 1 x 10-4 
-1 to <-½SD below the mean 8,499 147 0.80 (0.66 - 0.97) 0.91 (0.75 - 1.11) 
 ≥-½ to ≤½SD from the mean 15,507 372 1.00 1.00 
>½ to 1SD above the mean 5,128 125 1.10 (0.90 - 1.35) 0.96 (0.78 - 1.18) 
>1 to 2SD above the mean 5,307 149 1.57 (1.29 - 1.90) 1.33 (1.09 - 1.61) 
>2SD above the mean 1,636 45 2.64 (1.93 - 3.62) 1.79 (1.30 - 2.47) 
Hip circumference (cm) 
   <-1SD below the mean 5,716 100 1.35 (1.07 - 1.70) 8 x 10-8 1.37 (1.09 - 1.74) 2 x 10-3 
-1 to <-½SD below the mean 8,358 142 1.11 (0.91 - 1.35) 1.20 (0.98 - 1.46) 
 ≥-½ to ≤½SD from the mean 17,334 335 1.00 1.00 
>½ to 1SD above the mean 5,065 135 1.25 (1.02 - 1.53) 1.13 (0.93 - 1.39) 
>1 to 2SD above the mean 4,586 143 1.53 (1.25 - 1.86) 1.31 (1.08 - 1.60) 
>2SD above the mean 1,733 60 2.17 (1.64 - 2.86) 1.66 (1.25 - 2.20) 
Waist & hip circumference 
   Waist 
   <-1SD below the mean 6,715 77 0.43 (0.32 - 0.59) 1 x 10-12 0.53 (0.39 - 0.73) 5 x 10-5 
 -1 to <-½SD below the mean 8,499 147 0.64 (0.52 - 0.79) 0.75 (0.61 - 0.94) 
 ≥-½ to ≤½SD from the mean 15,507 372 1.00 1.00 
 >½ to 1SD above the mean 5,128 125 1.16 (0.93 - 1.45) 0.99 (0.79 - 1.23) 
 >1 to 2SD above the mean 5,307 149 1.65 (1.29 - 2.11) 1.34 (1.04 - 1.72) 
 >2SD above the mean 1,636 45 2.77 (1.84 - 4.18) 1.76 (1.16 - 2.66) 
   Hip 
   <-1SD below the mean 5,716 100 2.30 (1.73 - 3.06) 1 x 10-6 1.97 (1.48 - 2.62) 3 x 10-4 
 -1 to <-½SD below the mean 8,358 142 1.46 (1.18 - 1.81) 1.41 (1.14 - 1.75) 
 ≥-½ to ≤½SD from the mean 17,334 335 1.00 1.00 
 >½ to 1SD above the mean 5,065 135 1.03 (0.83 - 1.27) 1.04 (0.84 - 1.29) 
 >1 to 2SD above the mean 4,586 143 1.02 (0.80 - 1.30) 1.06 (0.83 - 1.36) 
 >2SD above the mean 1,733 60 1.03 (0.71 - 1.50) 1.12 (0.77 - 1.62) 
$   HR hazard ratio. CI confidence interval. Estimated separately for males and females using Cox proportional 
hazards models, stratified by cohort, with age at death/censoring as the time variable. #   Adjusted for age at 
baseline. &   Adjusted for age at baseline, log of total cholesterol (mmol/l), log of HDL cholesterol (mmol/l), 
systolic blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, 
cigars/cigarillos or pipe), diabetes, and an interaction between age at baseline and systolic blood pressure. +   
Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. †   A body 
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Table S7. Estimated risk of death from cardiovascular disease among males (N= 47,695) according to 
categorical body measurement categories under partial and full adjustment$ 
Body measurement Number of Number of Partially adjusted# Further adjusted&
people deaths HR (95% CI) p-value  HR (95% CI) p-value 
Body mass index (kg/m2)+ 
   <-1SD below the mean 6,652 212 1.07 (0.91 - 1.25) 8 x 10-12 1.17 (0.99 - 1.37) 5 x 10-3 
-1 to <-½SD below the mean 8,667 272 0.99 (0.86 - 1.14) 1.07 (0.93 - 1.24) 
 ≥-½ to ≤½SD from the mean 19,741 651 1.00 1.00 
>½ to 1SD above the mean 5,964 220 1.22 (1.04 - 1.42) 1.12 (0.96 - 1.30) 
>1 to 2SD above the mean 4,944 222 1.44 (1.23 - 1.68) 1.19 (1.02 - 1.39) 
>2SD above the mean 1,727 85 2.12 (1.69 - 2.67) 1.53 (1.21 - 1.93) 
Waist-to-hip ratio 
  <-1SD below the mean 6,513 170 0.78 (0.65 - 0.93) 2 x 10-26 0.93 (0.78 - 1.11) 3 x 10-9 
-1 to <-½SD below the mean 9,329 235 0.73 (0.63 - 0.85) 0.81 (0.69 - 0.94) 
 ≥-½ to ≤½SD from the mean 17,944 607 1.00 1.00 
>½ to 1SD above the mean 6,672 280 1.30 (1.13 - 1.50) 1.21 (1.04 - 1.39) 
>1 to 2SD above the mean 5,917 300 1.64 (1.42 - 1.89) 1.40 (1.21 - 1.62) 
>2SD above the mean 1,320 70 2.04 (1.59 - 2.63) 1.50 (1.16 - 1.93) 
A body shape index† 
  <-1SD below the mean 7,045 160 0.88 (0.74 - 1.06) 1 x 10-24 1.01 (0.84 - 1.21) 2 x 10-15 
-1 to <-½SD below the mean 7,334 151 0.74 (0.62 - 0.88) 0.79 (0.66 - 0.94) 
 ≥-½ to ≤½SD from the mean 19,238 600 1.00 1.00 
>½ to 1SD above the mean 7,129 293 1.20 (1.04 - 1.38) 1.16 (1.01 - 1.34) 
>1 to 2SD above the mean 5,878 367 1.65 (1.44 - 1.88) 1.51 (1.32 - 1.73) 
>2SD above the mean 1,071 91 2.21 (1.77 - 2.77) 1.94 (1.55 - 2.44) 
Waist-to-height ratio 
  <-1SD below the mean 7,140 167 0.96 (0.80 - 1.14) 6 x 10-30 1.08 (0.90 - 1.30) 4 x 10-11 
-1 to <-½SD below the mean 8,069 208 0.84 (0.72 - 0.99) 0.93 (0.79 - 1.09) 
 ≥-½ to ≤½SD from the mean 19,175 606 1.00 1.00 
>½ to 1SD above the mean 6,307 294 1.44 (1.25 - 1.66) 1.31 (1.14 - 1.51) 
>1 to 2SD above the mean 5,432 281 1.66 (1.44 - 1.92) 1.40 (1.21 - 1.62) 
>2SD above the mean 1,572 106 2.66 (2.16 - 3.29) 1.95 (1.58 - 2.42) 
Waist circumference (cm) 
   <-1SD below the mean 6,922 187 1.00 (0.85 - 1.18) 9 x 10-21 1.11 (0.94 - 1.32) 9 x 10-7 
-1 to <-½SD below the mean 8,870 228 0.86 (0.74 - 1.00) 0.94 (0.80 - 1.09) 
 ≥-½ to ≤½SD from the mean 18,641 600 1.00 1.00 
>½ to 1SD above the mean 6,277 260 1.23 (1.07 - 1.43) 1.13 (0.97 - 1.31) 
>1 to 2SD above the mean 5,483 298 1.60 (1.39 - 1.84) 1.35 (1.17 - 1.55) 
>2SD above the mean 1,502 89 2.27 (1.81 - 2.84) 1.69 (1.35 - 2.13) 
Hip circumference (cm) 
   <-1SD below the mean 6,643 192 1.25 (1.06 - 1.49) 2 x 10-9 1.31 (1.10 - 1.56) 5 x 10-5 
-1 to <-½SD below the mean 8,309 244 1.03 (0.88 - 1.19) 1.07 (0.92 - 1.24) 
 ≥-½ to ≤½SD from the mean 19,383 627 1.00 1.00 
>½ to 1SD above the mean 6,793 282 1.13 (0.98 - 1.30) 1.09 (0.94 - 1.25) 
>1 to 2SD above the mean 5,170 235 1.36 (1.17 - 1.58) 1.21 (1.04 - 1.41) 
>2SD above the mean 1,397 82 2.04 (1.62 - 2.58) 1.68 (1.33 - 2.12) 
Waist & hip circumference 
  Waist 
   <-1SD below the mean 6,922 187 0.73 (0.59 - 0.89) 2 x 10-16 0.88 (0.72 - 1.09) 7 x 10-5 
 -1 to <-½SD below the mean 8,870 228 0.75 (0.63 - 0.88) 0.85 (0.72 - 1.00) 
 ≥-½ to ≤½SD from the mean 18,641 600 1.00 1.00 
 >½ to 1SD above the mean 6,277 260 1.36 (1.16 - 1.59) 1.20 (1.02 - 1.40) 
 >1 to 2SD above the mean 5,483 298 1.85 (1.55 - 2.20) 1.46 (1.22 - 1.73) 
 >2SD above the mean 1,502 89 2.55 (1.87 - 3.47) 1.70 (1.25 - 2.32) 
   Hip 
   <-1SD below the mean 6,643 192 1.72 (1.39 - 2.12) 6 x 10-6 1.51 (1.22 - 1.87) 3 x 10-3 
 -1 to <-½SD below the mean 8,309 244 1.26 (1.07 - 1.48) 1.19 (1.01 - 1.39) 
 ≥-½ to ≤½SD from the mean 19,383 627 1.00 1.00 
 >½ to 1SD above the mean 6,793 282 0.88 (0.75 - 1.02) 0.94 (0.81 - 1.10) 
 >1 to 2SD above the mean 5,170 235 0.84 (0.70 - 1.02) 0.92 (0.76 - 1.11) 
 >2SD above the mean 1,397 82 0.96 (0.70 - 1.32) 1.11 (0.81 - 1.52) 
$   HR hazard ratio. CI confidence interval. Estimated separately for males and females using Cox proportional 
hazards models, stratified by cohort, with age at death/censoring as the time variable. #   Adjusted for age at 
baseline.&   Adjusted for age at baseline, log of total cholesterol (mmol/l), log of HDL cholesterol (mmol/l), 
systolic blood pressure (mm Hg), taking antihypertensive drugs, current daily smoker (cigarettes, 
cigars/cigarillos or pipe), diabetes, and an interaction between age at baseline and current daily smoker. +   
Body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. †   A body 
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Figure S1. Risk of all-cause death according to obesity measures by sex and daily smoking status for all participants, estimated after adjustment for 
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Hazard ratios for all-cause death by sex (panel A = Female; panel B = Male), with 95% confidence intervals, are shown for each obesity measure: BMI (body mass index - 
the weight in kilograms divided by the square of the height in meters), WHR (weight-to-hip ratio), ABSI (a body shape index: waist circumference in metres/(BMI2/3 
*height in meters1/2)), WHtR (weight-to-height ratio), WC and HC). Vertical lines indicate 95% confidence intervals. Reference category for each obesity measure was –½
standard deviation (SD) to ½SD from the sample sex-specific mean calculated using all participants. Risks were estimated from Cox proportional hazards models, stratified
by cohort, and adjusted for age at baseline, log of total cholesterol (mmol/l), log of high density lipoprotein (HDL) cholesterol (mmol/l), systolic blood pressure (mm Hg),
taking antihypertensive drugs, diabetes, current daily smoker and interaction between obesity measure and current daily smoker, and all interactions between age and other
baseline measures that were statistically significant (p<0.001). †   Additionally adjusted for an interaction between age at baseline and log of HDL cholesterol (mmol/l).  &
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